Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium
- Author:
Sunmin PARK
1
;
Won Sup YOON
;
Hyung Joon YIM
;
Chai Hong RIM
Author Information
- Publication Type:Case Report
- Keywords: Liver neoplasm; Inferior vena cava; Right atrium; Radiotherapy
- MeSH: Carcinoma, Hepatocellular; Disease-Free Survival; Drug Therapy; Follow-Up Studies; Heart Atria; Humans; Liver Neoplasms; Radiotherapy; Vena Cava, Inferior
- From:Journal of Liver Cancer 2019;19(2):149-153
- CountryRepublic of Korea
- Language:English
- Abstract: Hepatocellular carcinoma (HCC) involving the inferior vena cava (IVC) and/or right atrium (RA) is a rare and intractable disease. A standard treatment has not been established yet, owing to the rarity of disease and difficulties in the therapeutic treatment. Herein, we report the case of a patient who had recurrent HCC (after a prior lobectomy) involving both IVC and RA and underwent multimodality treatments including external beam radiotherapy and transarterial chemotherapy, followed by sorafenib treatment. The disease was well controlled with local treatments and sustained for 7 years until last follow-up after the systemic treatments. Our case shows a possibility of long-term survival for patients affected by HCC involving IVC and/or RA, after a rigorous multimodality treatment strategy.
